NYSE:SNN (Smith & Nephew plc)
About SNN
Smith+Nephew is a portfolio medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 17,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Smith & Nephew plc (NYSE: SNN) Latest News
Investing Articles
Should You Buy Neil Woodford Rejects HSBC Holdings plc, Reckitt Benckiser Group Plc And Smith & Nephew plc?
Investing Articles
3 FTSE 100 Stocks Set To Soar: SSE PLC, Smith & Nephew plc And Burberry Group plc
Investing Articles
AstraZeneca plc vs Smith & Nephew plc vs Indivior PLC: Which Healthcare Stock Should You Buy?
Investing Articles
Is The Reward Worth The Risk With BT Group plc, Admiral Group PLC, Smith & Nephew plc And Associated British Foods plc?
Investing Articles
Why Neil Woodford Has Sold Smith & Nephew Plc But Bought More Centrica Plc And SSE Plc
Investing Articles
Keep An Eye On Smith & Nephew plc & Shire plc Now!
Investing Articles
Don’t Make These Basic Mistakes With BHP Billiton plc, Smith & Nephew plc And Tungsten Corp PLC
Investing Articles
AstraZeneca plc vs Smith & Nephew plc: Which Is The Better Buy?
Investing Articles
Why Now Is A Great Opportunity To Take Profit On Takeover Target Smith & Nephew plc
Investing Articles
Why Smith & Nephew plc Is Attracting Interest From Stryker Corporation
Investing Articles
3 Neil Woodford Plays On Ageing Populations: AstraZeneca plc, Smith & Nephew plc And Capita PLC
Investing Articles
Is It Time To Cash In On Takeover Target Smith & Nephew plc?
1❯